Ameritas Investment Partners Inc. Grows Stock Holdings in Sotera Health (NASDAQ:SHC)

Ameritas Investment Partners Inc. raised its stake in shares of Sotera Health (NASDAQ:SHC) by 24.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 27,584 shares of the company’s stock after buying an additional 5,400 shares during the period. Ameritas Investment Partners Inc.’s holdings in Sotera Health were worth $331,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of SHC. Principal Financial Group Inc. lifted its position in shares of Sotera Health by 27.6% during the 1st quarter. Principal Financial Group Inc. now owns 468,500 shares of the company’s stock valued at $5,627,000 after buying an additional 101,430 shares in the last quarter. Findell Capital Management LLC bought a new position in Sotera Health during the fourth quarter valued at approximately $8,425,000. P2 Capital Partners LLC grew its holdings in Sotera Health by 27.0% during the 4th quarter. P2 Capital Partners LLC now owns 2,350,000 shares of the company’s stock valued at $39,598,000 after buying an additional 500,000 shares in the last quarter. Tyro Capital Management LLC bought a new stake in Sotera Health in the 4th quarter worth approximately $15,761,000. Finally, Dimensional Fund Advisors LP increased its position in Sotera Health by 22.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,992,717 shares of the company’s stock worth $33,581,000 after purchasing an additional 363,628 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Up 0.4 %

Shares of NASDAQ SHC opened at $13.38 on Thursday. The business’s 50 day moving average price is $11.86 and its 200-day moving average price is $12.95. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $19.20. The company has a debt-to-equity ratio of 5.39, a quick ratio of 2.86 and a current ratio of 3.20. The company has a market cap of $3.79 billion, a price-to-earnings ratio of 70.42 and a beta of 2.06.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $248.18 million for the quarter, compared to the consensus estimate of $254.73 million. Sotera Health had a net margin of 5.09% and a return on equity of 48.47%. On average, sell-side analysts expect that Sotera Health will post 0.63 earnings per share for the current year.

Analysts Set New Price Targets

SHC has been the subject of several recent research reports. Barclays dropped their price target on Sotera Health from $19.00 to $14.00 and set an “overweight” rating for the company in a research report on Wednesday, April 10th. Piper Sandler assumed coverage on Sotera Health in a research note on Tuesday, May 21st. They issued a “neutral” rating and a $13.00 price objective for the company. Finally, Citigroup raised Sotera Health from a “neutral” rating to a “buy” rating and cut their target price for the company from $18.00 to $16.00 in a research report on Wednesday, April 3rd. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.92.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.